UK exempts AI scribes from medical regulation
By classifying ambient AI scribes as administrative tools rather than medical devices, UK regulators are prioritizing clinical speed over systemic safety.
Dual AI models flag ICU sepsis early
A new dual-model AI system catches sepsis and infection hours before they turn fatal, shifting the ICU from reactive treatment to proactive defense.
Simulating clinical trials before patients enroll
Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.
Smartwatches fail to measure blood glucose levels
A rigorous new evaluation reveals that wrist-worn wearables capture no real blood glucose data, exposing a major flaw in non-invasive tracking claims.
First Hospital Earns National AI Safety Certification
As federal regulators struggle to keep pace with the clinical AI boom, private oversight is stepping in to draw the guardrails.
Artificial intelligence empowers full-stack histopathological diagnosis and prognosis of renal cell tumor: a multi-center study with external validation
A new AI model predicts kidney cancer survival better than the gold-standard human grading system.
AI intake tools expand to 100 clinics
Deploying diagnostic AI to vulnerable populations is a high-stakes test of whether technology can solve the physician shortage without worsening health disparities.
Hybrid novice-AI system achieves expert-level performance in intraoperative ischemia detection
Pairing untrained staff with artificial intelligence could solve the specialist shortage in operating rooms.
The Dermatology AI Report — August 2026
Dermoscopy-Based AI Risk Scoring Enhanced Experienced Dermatologists’ Decision-Making: a Large Retrospective Reader Study
Pathos AI Bets Big on Clinical Rescue
A young startup is spending hundreds of millions to prove that artificial intelligence can salvage stalled drug pipelines.